AKT1 and diabetic cardiomyopathy: One study found KD treatment ameliorates cardiac dysfunction by inhibiting apoptosis via activating the PI3K-Akt pathway in type 2 diabetic mice, suggesting that the KD is a promising lifestyle intervention offering protection against diabetic cardiomyopathy (85).